发明名称 |
Combination of mTOR inhibitors and P13-kinase inhibitors, and uses thereof |
摘要 |
The present invention provides for a method for treating a disease condition associated with PI3-kinase α and/or mTOR in a subject. In another aspect, the invention provides for a method for treating a disease condition associated with PI3-kinase α and/or mTOR in a subject. In yet another aspect, a method of inhibiting phosphorylation of both Akt (S473) and Akt (T308) in a cell is set forth. |
申请公布号 |
US9295673(B2) |
申请公布日期 |
2016.03.29 |
申请号 |
US201213403856 |
申请日期 |
2012.02.23 |
申请人 |
Intellikine LLC |
发明人 |
Ren Pingda;Liu Yi;Jessen Katayoun;Guo Xin;Rommel Christian;Wilson Troy Edward |
分类号 |
A61K31/551;A61K31/4439;A61K31/4745;A61K31/498;A61K45/06;A61K31/501;A61K31/517;A61K31/519;A61K31/527;A61K31/53;A61K31/5377;A61K31/541 |
主分类号 |
A61K31/551 |
代理机构 |
Honigman Miller Schwartz and Cohn LLP |
代理人 |
Honigman Miller Schwartz and Cohn LLP ;Yang Lucy X.;O'Brien Jonathan P. |
主权项 |
1. A method for treating breast cancer comprising administering to a subject in need thereof a therapeutically effective amount of the mTOR inhibitor: or a pharmaceutically acceptable salt thereof; and a therapeutically effective amount of the PI3-kinase α inhibitor: or a pharmaceutically acceptable salt thereof. |
地址 |
La Jolla CA US |